Allianz Asset Management
MRNA icon

Allianz Asset Management’s Moderna MRNA Stock Holding History

Allianz Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.9M Sell
984,497
-4,411
-0.4% -$228K 0.06% 313
2026
Q1 		$50.2M Buy
988,908
+971,107
+5,455% +$45.3M 0.05% 327
2025
Q4 		$525K Buy
17,801
+9,534
+115% +$259K ﹤0.01% 1826
2025
Q3 		$214K Buy
+8,267
New +$231K ﹤0.01% 1948
2025
Q2 		– Sell
-54,512
Closed -$1.55M – 2197
2025
Q1 		$1.55M Sell
54,512
-43,134
-44% -$1.53M ﹤0.01% 1563
2024
Q4 		$4.06M Buy
97,646
+2,565
+3% +$123K 0.01% 1144
2024
Q3 		$6.35M Buy
95,081
+1,437
+2% +$132K 0.01% 919
2024
Q2 		$11.1M Buy
93,644
+8,251
+10% +$1.04M 0.02% 670
2024
Q1 		$9.1M Sell
85,393
-24,664
-22% -$2.49M 0.01% 681
2023
Q4 		$10.9M Sell
110,057
-167,470
-60% -$14.1M 0.02% 663
2023
Q3 		$28.7M Sell
277,527
-46,048
-14% -$5.14M 0.05% 375
2023
Q2 		$39.3M Sell
323,575
-62,132
-16% -$8.29M 0.07% 266
2023
Q1 		$59.2M Buy
385,707
+84,280
+28% +$13.9M 0.11% 190
2022
Q4 		$54.1M Buy
301,427
+25,400
+9% +$4.15M 0.11% 194
2022
Q3 		$32.6M Sell
276,027
-557,309
-67% -$84.6M 0.07% 306
2022
Q2 		$119M Buy
833,336
+18,931
+2% +$2.71M 0.11% 198
2022
Q1 		$140M Sell
814,405
-715,367
-47% -$120M 0.1% 206
2021
Q4 		$388M Buy
1,529,772
+521,834
+52% +$153M 0.27% 78
2021
Q3 		$388M Sell
1,007,938
-966,235
-49% -$356M 0.3% 69
2021
Q2 		$464M Sell
1,974,173
-638,178
-24% -$114M 0.39% 53
2021
Q1 		$342M Buy
2,612,351
+2,347,122
+885% +$340M 0.33% 69
2020
Q4 		$27.7M Sell
265,229
-88,362
-25% -$8.94M 0.03% 515
2020
Q3 		$25M Buy
353,591
+16,744
+5% +$1.17M 0.03% 494
2020
Q2 		$21.6M Buy
336,847
+17,023
+5% +$932K 0.03% 588
2020
Q1 		$9.58M Buy
+319,824
New +$7.36M 0.01% 868
2019
Q4 		– Sell
-10,030
Closed -$160K – 2820
2019
Q3 		$160K Buy
+10,030
New +$148K ﹤0.01% 2660

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Allianz Asset Management's MRNA Position: Q2 2026 in Review

Allianz Asset Management reduced its Moderna (MRNA) stake by 0.45% in Q2 2026, selling an estimated $228K and leaving 984,497 shares worth $68.9M. The position accounts for 0.06% of the portfolio, ranked #313.

Allianz Asset Management first reported a position in MRNA in Q3 2019 and has held it in 26 quarters since. The position peaked at $464M in Q2 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Allianz Asset Management held 984,497 shares of Moderna worth $68.9M as of Q2 2026.
  • Allianz Asset Management sold 4,411 Moderna shares in Q2 2026, an estimated $228K.
  • Moderna made up 0.06% of Allianz Asset Management's portfolio in Q2 2026, its #313 holding.
  • Allianz Asset Management first reported a position in Moderna in Q3 2019 and has held it in 26 quarters since.
  • Allianz Asset Management's Moderna position peaked at $464M in Q2 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.